Neurorehabilitation of Sequence Effect in Parkinson's Disease
Destination Sequence Effect Modifications After a 4-week Rehabilitation Program in Parkinson's Diseases Patients
1 other identifier
observational
43
1 country
1
Brief Summary
The sequence effect (SE), defined as a reduction in amplitude of repetitive movements, is a common clinical feature of Parkinson's disease (PD), being a major contributor to freezing of gait (FOG). During walking, SE manifests as a step-by-step reduction in step length when approaching a turn or gait destination (dSE). The investigators studied the effect of a 4-week rehabilitation program on the destination sequence effect in patients affected by Parkinson's disease with and without Freezing of Gait. All subjects were evaluated with inertial gait analysis for dSE recording.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2021
CompletedFirst Submitted
Initial submission to the registry
June 4, 2021
CompletedFirst Posted
Study publicly available on registry
June 10, 2021
CompletedJune 15, 2021
June 1, 2021
1.5 years
June 4, 2021
June 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Destination sequence effect (dSE) modifications
Using an inertial gait analysis we will explore the modifications of destination sequence effect in PD patients with and without freezing of gait treated with a 4-week in-hospital rehabilitation program
Change from baseline (T0) to four weeks (T1)
Secondary Outcomes (13)
Between-group comparison of dSE
Baseline (T0)
Gait hypokinesia modifications
Change from baseline (T0) to four weeks (T1)
Speed modifications
Change from baseline (T0) to four weeks (T1)
Cadence modifications
Change from baseline (T0) to four weeks (T1)
Stride duration modifications
Change from baseline (T0) to four weeks (T1)
- +8 more secondary outcomes
Study Arms (2)
PD+FOG group
Patients affected by Parkinson's Disease with freezing of gait (PD+FOG group)
PD-FOG group
Patients affected by Parkinson's Disease without freezing of gait (PD+FOG group)
Interventions
All patients will be treated with an in-hospital rehabilitation program focused on the rehabilitation of gait disorder in PD with 90-minute daily sessions, 6 days a week (Monday through Saturday) for four weeks. The rehabilitation treatment includes passive, active-assisted, and active exercises, isotonic and isometric exercises for the major muscles of the limbs and trunk, cardiovascular warm-up exercises, muscle stretching exercises for functional purposes, balance training exercises, specific motor exercise for hypokinesia, and 45 minutes of overground gait training delivered without devices or cueing The rehabilitation program is the same in PD patients with and without FOG.
Eligibility Criteria
Patients affected by Idiopathic Parkinson's disease with and without freezing of gait to be consecutively enroll among those attending the Neurorehabilitation Department of the IRCCS Mondino Foundation (Pavia, Italy)
You may qualify if:
- Idiopathic Parkinson's disease
- Hoehn and Yahr stage between I and IV
- Mini-Mental State Examination score above 24.
You may not qualify if:
- Major psychiatric or other neurological conditions,
- Rheumatological diseases
- Ophthalmic diseases
- Orthopedic diseases
- Ongoing or previous treatment with neuroleptic drugs
- Patients with deep brain stimulation
- Any change in dose or regimen of the anti-parkinsonian therapy in the last month before enrolment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Mondino Foundation
Pavia, 27100, Italy
Related Publications (2)
Kang SY, Wasaka T, Shamim EA, Auh S, Ueki Y, Lopez GJ, Kida T, Jin SH, Dang N, Hallett M. Characteristics of the sequence effect in Parkinson's disease. Mov Disord. 2010 Oct 15;25(13):2148-55. doi: 10.1002/mds.23251.
PMID: 20669182BACKGROUNDCao SS, Yuan XZ, Wang SH, Taximaimaiti R, Wang XP. Transverse Strips Instead of Wearable Laser Lights Alleviate the Sequence Effect Toward a Destination in Parkinson's Disease Patients With Freezing of Gait. Front Neurol. 2020 Aug 12;11:838. doi: 10.3389/fneur.2020.00838. eCollection 2020.
PMID: 32903360BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto De Icco, MD
IRCCS Mondino Foundation, Pavia
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 4, 2021
First Posted
June 10, 2021
Study Start
August 1, 2019
Primary Completion
January 31, 2021
Study Completion
February 28, 2021
Last Updated
June 15, 2021
Record last verified: 2021-06